A step further towards pharmaceutical innovation in 3D
MB Therapeutics has settled into its new premises. New address, same tight-knit team, and even more energy!
News
A week of pharmaceutical innovation for MB Therapeutics
From Rotterdam to Lyon… The MB Therapeutics team took part in key events where pharmaceutical innovation was at the heart of the discussions.
MB Therapeutics raises 2 million euros
MB Therapeutics raises €2 million to industrialize and launch a solution for the manufacturing of personalized medicines in pharmacies.
MB Therapeutics celebrates its firts anniversary!
A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.
MB Therapeutics expands its leadership team
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
GERPAC 2024 is coming soon!
Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!
MB Therapeutics receives the French Tech Emergence Grant
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
The regional fund Créalia is providing support to MB Therapeutics
The seed fund Créalia awards an innovation grant to MB Therapeutics for the development of its personalized medicine solution.